There are fresh doubts about ChemChina's proposed acquisition of Syngenta - amid increasing signs that the west is stiffening its opposition to Chinese takeovers of US and European companies. Andrew Parker discusses what's behind these doubts with the FT's Arash Massoudi and James Kynge.

Copyright The Financial Times Limited 2018. All rights reserved.

Comments have not been enabled for this podcast.